Utility of Non-invasive Carboxyhemoglobin and Total Hemoglobin Measurement in the Emergency Department
NCT ID: NCT03017742
Last Updated: 2022-07-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
813 participants
INTERVENTIONAL
2016-11-30
2017-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Non-Invasive Hemoglobin in Trauma Patients
NCT03123328
Dysfunctional Hemoglobin Pulse Oximetry
NCT03030833
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
NCT03610269
Suspected Cases of Carbon Monoxide Poisoning
NCT02950701
Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
NCT01997502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Group
The subjects enrolled in the test group will receive the pulse oximeter
Pulse Oximeter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulse Oximeter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one digit has acceptable width as measured by study-provided digit gauge.
* Presenting to emergency department for any complaint.
* Potential for IV catheter and/or blood draw for CBC as standard of care.
Exclusion Criteria
* Patients with fingernail polish, discoloration or trauma to fingers
1 Year
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Masimo Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tepecik Training and Research Hospital IEC
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SUNE0002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.